Is this 2 day drop overdone?It's now much below the recent $11.75 share offering price(had thought that would've been the floor).It had probably gone up on the hype,but isn't this drop looking overdone,that too when it's not on company-specific news,but just in sympathy with BIIB?
Would like to hear thoughts of those who've followed this company ,the science,and the Alzheimer's disease group.Thanks